Company Search:
Advanced Search
Sponsored Links
Pierrel Company Snapshot
Pierrel operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other pharmaceutical manufacturers in Europe: Science In Sport Plc of the United Kingdom (2016 sales of £12.24 million [US$17.10 million] ), Replek AD Skopje of Macedonia (829.32 million Denar [US$16.65 million] ), and Photocure ASA which is based in Norway (143.63 million Norwegian Kroner [US$18.58 million] of which 48% was Hexvix/Cysview Own Sales).

Sales Analysis. During the year ended December of 2016, sales at Pierrel were 14.27 million Euro (US$17.64 million). This is a decrease of 10.2% versus 2015, when the company's sales were 15.89 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Pierrel
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): .21
(Figures in Euro)
1 Week 2.0%   13 Weeks -4.1%  
4 Weeks 8.9%   52 Weeks -14.3%  
Pierrel Key Data:
  Ticker: PRL Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 14,272,000
(Year Ending Jan 2017).
Employees: 305
  Currency: Euro Market Cap: 11,302,526
  Fiscal Yr Ends: December Shares Outstanding: 54,079,073
  Share Type: Aziohi Ordinaire Closely Held Shares: 28,124,071
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.